Implantable Intracranial Pulse Pressure Modulator and System and Method for Use of Same

Abstract

An implantable intracranial pulse pressure modulator for treating hydrocephalus in patients of all ages is disclosed as well as a system and method for use of the same. In one embodiment of the implantable intracranial pulse pressure modulator, two one-way valves are interposed in parallel, opposing orientations between a vestibule and a chamber. One of the one-way valves, in response to systole, provides fluid communication from the vestibule to the chamber such that a small aliquot of cerebrospinal fluid (CSF) is displaced from a cerebral ventricle into a ventricular catheter, thereby reducing intraventricular systolic pressure. The other one-way valve, in response to diastole, provides fluid communication from the chamber to the vestibule such that the same volume of CSF is reintroduced into a cerebral ventricle, thereby increasing intraventricular diastolic pressure. Together, both processes work synergistically to reduce intraventricular pulse pressure in order to treat hydrocephalus.

Description

PRIORITY STATEMENT & CROSS-REFERENCE TO RELATED APPLICATIONS[0001]This application claims priority of co-pending U.S. Patent Application Ser. No. 62 / 972,617, entitled “Implantable Intracranial Pulse Pressure Modulator and System and Method for Use of Same,” and filed on Feb. 10, 2020, in the name of Frederick H. Sklar; which is hereby incorporated by reference, in entirety, for all purposes.TECHNICAL FIELD OF THE INVENTION[0002]This invention relates, in general, to the treatment of hydrocephalus and, in particular, to an implantable surgical device, namely, an implantable intracranial pulse pressure modulator for treating hydrocephalus.BACKGROUND OF THE INVENTION[0003]Cerebrospinal fluid (CSF) is made within the cerebral ventricles by both active and passive processes. CSF percolates through the cerebral ventricular system, as well as the brain itself, and it is ultimately absorbed into intracranial and intraspinal veins, thereby establishing a so-called CSF circulation. It is gene...

AI Technical Summary

Benefits of technology

[0009]It would be advantageous to achieve an advanced, implantable device that can treat hydrocephalus without having to drain CSF from the cerebral ventricles to another body cavity. Moreover, it would be preferable if this device were designed for simplicity and to function passively, utilizing physiologic pressure changes that occur within the c

Problems solved by technology

In addition, processes that physically deform the brain or obstruct the ventricular system can block CSF pathways and flow, such as seen with tumors, cysts, and various congenital malformations.

In contrast, CSF absorption is a very sensitive function of ICP, increasing with increasing pressure over a threshold pressure even in patients with hydrocephalus, although perhaps not as efficiently as in normal individuals.

Sometimes after multiple VP shunts and/or infections involving the peritoneal cavity, VP shunts are not successful because of peritoneal adhesions, loculations, or an inability for the diverted CSF to be resorbed.

These various ventricular shunts present their own set of risks and complications, and they are considered distant second choice procedures to the VP shunt.

Overall, patients generall

Images